Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL18708 | 1.00 | — | — | |
| SCHEMBL27948499 | 1.00 | — | — | |
| Iodide SCHEMBL11424244 | 1.00 | — | — | |
| Iodide SCHEMBL9791887 | 0.82 | — | — | |
| Iodide SCHEMBL8901438 | 0.82 | — | — | |
| Bromide SCHEMBL11505479 | 0.82 | — | — | |
| Iodide SCHEMBL28519642 | 0.82 | — | — | |
| Iodide SCHEMBL4416035 | 0.82 | — | — | |
| Iodide SCHEMBL9064090 | 0.82 | — | — | |
| Iodide SCHEMBL4204495 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6624143-B1 | Antibiotics of the amphomycin type are characterized by the exocyclic amino acid aspartic acid (Asp, cyclic oligopeptides Antimicrobial Agents and Chemotherapy | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2003-09-23 | — | — | US | disclosed |